Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) PT Raised to $56 at Craig-Hallum; 'Valuation Remains a Concern'

February 7, 2018 9:07 AM EST

Craig-Hallum raised its price target on Haemonetics (NYSE: HAE) to $56.00 (from $50.00) while maintaining a Hold rating.

... More

Haemonetics (HAE) Tops Q3 Views; Announces $260M Stock Buyback Plan

February 6, 2018 6:13 AM EST

Haemonetics (NYSE: HAE) reported Q3 EPS of $0.62, which may note compare to the analyst estimate of $0.44. Revenue for the quarter came in at $234 million versus the consensus estimate of $227.67 million.

Chris Simon, Haemonetics CEO, stated: Our strategy is working and we have good momentum... More